Nika Pharmaceuticals, Inc. (NIKA)
OTCMKTS · Delayed Price · Currency is USD
0.9574
0.00 (0.00%)
At close: Sep 5, 2025

Nika Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-0.06-0.1-0.06-3.18-0.01-0.01
Stock-Based Compensation
---0.15--
Other Operating Activities
0.01-0.04-3--
Change in Other Net Operating Assets
-0.02-0.02----
Operating Cash Flow
-0.07-0.15-0.06-0.03-0.01-0.01
Short-Term Debt Issued
-0.140.080.02--
Long-Term Debt Issued
----0.010.01
Total Debt Issued
0.080.140.080.020.010.01
Net Debt Issued (Repaid)
0.080.140.080.020.010.01
Issuance of Common Stock
---0.01--
Financing Cash Flow
0.080.140.080.030.010.01
Net Cash Flow
0.01-0.020.020-00
Levered Free Cash Flow
0.16-0.08-0.041.15--
Unlevered Free Cash Flow
0.16-0.08-0.041.15--
Change in Working Capital
-0.02-0.02----
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.